{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Emergent BioSolutions Inc."},"Symbol":{"label":"Symbol","value":"EBS"},"Address":{"label":"Address","value":"400 PROFESSIONAL DRIVE,SUITE 400, GAITHERSBURG, Maryland, 20879, United States"},"Phone":{"label":"Phone","value":"+1 240 631-3200"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccine, device, and therapeutic products."},"CompanyUrl":{"label":"Company Url","value":"https://www.emergentbiosolutions.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Joseph C. Papa","title":"President, Chief Executive Officer & Director"},{"name":"Kelly Warfield","title":"Senior Vice President-Science & Development"},{"name":"Simon Lowry","title":"Chief Medical Officer, Head-Research & Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}